Barbara Fingleton

14.4k total citations · 5 hit papers
94 papers, 11.7k citations indexed

About

Barbara Fingleton is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Barbara Fingleton has authored 94 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Cancer Research, 50 papers in Oncology and 37 papers in Molecular Biology. Recurrent topics in Barbara Fingleton's work include Protease and Inhibitor Mechanisms (40 papers), Peptidase Inhibition and Analysis (32 papers) and Cell Adhesion Molecules Research (15 papers). Barbara Fingleton is often cited by papers focused on Protease and Inhibitor Mechanisms (40 papers), Peptidase Inhibition and Analysis (32 papers) and Cell Adhesion Molecules Research (15 papers). Barbara Fingleton collaborates with scholars based in United States, Japan and Canada. Barbara Fingleton's co-authors include Lynn M. Matrisian, Lisa M. Coussens, Howard C. Crawford, Mace L. Rothenberg, Amy R. Nelson, Conor C. Lynch, Tracy Vargo-Gogola, Gemma Shay, David P. Carbone and Yu Shyr and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Barbara Fingleton

92 papers receiving 11.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

2002 2.2k citations Lisa M. Coussens, Barbara Fingleton et al. profile →
Matrix Metalloproteinases: Biologic Activity and Clinical Implications

2000 1.3k citations Barbara Fingleton, Lynn M. Matrisian et al. profile →
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

2004 936 citations Yang Li, Laura M. DeBusk et al. Cancer Cell profile →
The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors

1999 581 citations Howard C. Crawford, Barbara Fingleton et al. Oncogene profile →
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1

2001 557 citations Barbara Fingleton, Howard C. Crawford et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Fingleton United States	48	5.1k	5.1k	5.1k	2.2k	1.4k	94	11.7k
Raffaella Giavazzi Italy	57	4.0k 0.8×	6.2k 1.2×	3.4k 0.7×	1.4k 0.7×	1.3k 1.0×	232	11.4k
Menashe Bar‐Eli United States	68	4.2k 0.8×	6.9k 1.4×	2.6k 0.5×	2.9k 1.4×	1.2k 0.9×	186	12.0k
Reuven Reich Israel	59	3.0k 0.6×	5.4k 1.1×	3.4k 0.7×	1.8k 0.9×	1.4k 1.1×	202	11.2k
Jian Cao United States	49	3.9k 0.8×	4.6k 0.9×	4.7k 0.9×	1.0k 0.5×	1.2k 0.9×	131	9.9k
Stanley Zucker United States	55	4.2k 0.8×	4.2k 0.8×	4.8k 0.9×	1.2k 0.6×	1.1k 0.8×	161	9.6k
Andreas Scorilas Greece	60	3.6k 0.7×	7.3k 1.4×	3.9k 0.8×	1.0k 0.5×	834 0.6×	429	13.8k
Elena I. Deryugina United States	46	3.6k 0.7×	3.8k 0.7×	3.8k 0.7×	1.4k 0.6×	1.8k 1.4×	71	9.4k
Corazon D. Bucana United States	66	4.6k 0.9×	8.2k 1.6×	3.6k 0.7×	2.0k 0.9×	786 0.6×	145	13.9k
Yuji Hinoda Japan	56	3.0k 0.6×	6.5k 1.3×	2.7k 0.5×	1.8k 0.8×	686 0.5×	272	10.3k
Evelyn Flynn United States	36	2.5k 0.5×	6.8k 1.3×	3.1k 0.6×	864 0.4×	1.1k 0.8×	66	11.4k

Countries citing papers authored by Barbara Fingleton

Since Specialization

Citations

This map shows the geographic impact of Barbara Fingleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Fingleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Fingleton more than expected).

Fields of papers citing papers by Barbara Fingleton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Fingleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Fingleton. The network helps show where Barbara Fingleton may publish in the future.

Co-authorship network of co-authors of Barbara Fingleton

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Fingleton. A scholar is included among the top collaborators of Barbara Fingleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Fingleton. Barbara Fingleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cottam, Matthew A., Hanbing An, Brian D. Lehmann, et al.. (2025). Comparison of Lean, Obese, and Weight-Loss Models Reveals TREM2 Deficiency Attenuates Breast Cancer Growth Uniquely in Lean Mice and Alters Clonal T-cell Populations. Cancer Research. 85(7). 1219–1235.

Fingleton, Barbara, et al.. (2023). The influence of sex on the immune microenvironment in male and female breast cancer. The Journal of Immunology. 210(Supplement_1). 88.17–88.17. 1 indexed citations

Fingleton, Barbara, et al.. (2019). Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis. Clinical & Experimental Metastasis. 36(3). 211–224. 14 indexed citations

Zaynagetdinov, Rinat, Taylor P. Sherrill, Linda A. Gleaves, et al.. (2015). Interleukin-5 Facilitates Lung Metastasis by Modulating the Immune Microenvironment. Cancer Research. 75(8). 1624–1634. 98 indexed citations

Carter, Kathy J., et al.. (2014). IL4 Receptor ILR4α Regulates Metastatic Colonization by Mammary Tumors through Multiple Signaling Pathways. Cancer Research. 74(16). 4329–4340. 76 indexed citations

Petersen, Christine, Victoria G. Weis, Ki Taek Nam, et al.. (2014). Macrophages Promote Progression of Spasmolytic Polypeptide-Expressing Metaplasia After Acute Loss of Parietal Cells. Gastroenterology. 146(7). 1727–1738.e8. 102 indexed citations

Barham, Whitney, Andrea L. Frump, Taylor P. Sherrill, et al.. (2013). Targeting the Wnt Pathway in Synovial Sarcoma Models. Cancer Discovery. 3(11). 1286–1301. 57 indexed citations

Barrett, Caitlyn W., J. Joshua Smith, Nicholas O. Markham, et al.. (2012). Kaiso Directs the Transcriptional Corepressor MTG16 to the Kaiso Binding Site in Target Promoters. PLoS ONE. 7(12). e51205–e51205. 20 indexed citations

Barrett, Caitlyn W., Barbara Fingleton, Ning Wei, et al.. (2011). MTGR1 Is Required for Tumorigenesis in the Murine AOM/DSS Colitis-Associated Carcinoma Model. Cancer Research. 71(4). 1302–1312. 31 indexed citations

10.

Stathopoulos, Georgios T., Taylor P. Sherrill, Sophia P. Karabela, et al.. (2010). Host-derived Interleukin-5 Promotes Adenocarcinoma-induced Malignant Pleural Effusion. American Journal of Respiratory and Critical Care Medicine. 182(10). 1273–1281. 47 indexed citations

11.

Koon, Henry, Barbara Fingleton, Jeannette Y. Lee, et al.. (2010). Phase II AIDS Malignancy Consortium Trial of Topical Halofuginone in AIDS-Related Kaposi Sarcoma. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(1). 64–68. 47 indexed citations

12.

Martin, Michelle D., Kathy J. Carter, Mayland Chang, et al.. (2008). Effect of Ablation or Inhibition of Stromal Matrix Metalloproteinase-9 on Lung Metastasis in a Breast Cancer Model Is Dependent on Genetic Background. Cancer Research. 68(15). 6251–6259. 99 indexed citations

13.

Quarles, C. Chad, Martin Lepage, D. Lee Gorden, et al.. (2008). Functional colonography of Min mice using dark lumen dynamic contrast‐enhanced MRI. Magnetic Resonance in Medicine. 60(3). 718–726. 9 indexed citations

14.

Sinnamon, Mark J., Kathy J. Carter, Barbara Fingleton, & Lynn M. Matrisian. (2008). Matrix metalloproteinase‐9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse. International Journal of Experimental Pathology. 89(6). 466–475. 33 indexed citations

15.

Lynch, Conor C., Tracy Vargo-Gogola, Michelle D. Martin, et al.. (2007). Matrix Metalloproteinase 7 Mediates Mammary Epithelial Cell Tumorigenesis through the ErbB4 Receptor. Cancer Research. 67(14). 6760–6767. 55 indexed citations

16.

Schwartz, Donald R., Kamiar Moin, Bin Yao, et al.. (2007). Hu/Mu ProtIn Oligonucleotide Microarray: Dual-Species Array for Profiling Protease and Protease Inhibitor Gene Expression in Tumors and Their Microenvironment. Molecular Cancer Research. 5(5). 443–454. 14 indexed citations

17.

Fingleton, Barbara, William C. Powell, Howard C. Crawford, John Couchman, & Lynn M. Matrisian. (2007). A Rat Monoclonal Antibody That Recognizes Pro- And Active MMP-7 Indicates Polarized Expression In Vivo. Hybridoma. 26(1). 22–27. 18 indexed citations

18.

Li, Yang, Laura M. DeBusk, Barbara Fingleton, et al.. (2004). Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell. 6(4). 409–421. 936 indexed citations breakdown →

19.

Gustavson, Mark, Howard C. Crawford, Barbara Fingleton, & Lynn M. Matrisian. (2004). Tcf binding sequence and position determines β‐catenin and Lef‐1 responsiveness of MMP‐7 promoters. Molecular Carcinogenesis. 41(3). 125–139. 42 indexed citations

20.

Crawford, Howard C., Barbara Fingleton, Laura A. Rudolph‐Owen, et al.. (1999). The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene. 18(18). 2883–2891. 581 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact